Latest Strategy News

Scentre Group reported robust 2025 results with a 4.9% rise in Funds From Operations and record customer visitation, while progressing key sustainability and growth initiatives.

Scentre Group has reported a robust 2025 financial year with Funds From Operations rising 4.9% and distributions up 3.4%, underpinned by record occupancy and strong customer engagement. The Group also advanced its sustainability agenda, exceeding interim net zero targets and progressing major redevelopment projects.

Olympio Metals has secured binding agreements to acquire two historically high-grade silver and antimony projects in the US, backed by a $3 million capital raise including vendor participation.

Greenwing Resources has significantly enhanced the economics of its Que River Project following a sharp rise in key metal prices, nearly doubling projected cash flows and advancing a two-stage development plan.

Bass Oil has received a $3.5 million grant from the South Australian Government to fund pipeline construction for its Kiwi liquids rich gas project in the Cooper Basin, marking a key step towards production by 2028.

European Resources Limited has reported its strongest rare earth drilling results yet at the Korsnäs project in Finland, revealing a significant neodymium-praseodymium enriched zone and confirming the effectiveness of passive seismic targeting.

Argent Minerals has confirmed visible gold at its Kempfield and Trunkey Creek projects in New South Wales, highlighting promising high-grade gold shoots and expanding exploration potential. The company plans systematic drilling to further define these multi-metal deposits.

Ballymore Resources is progressing development at its high-grade Dittmer Gold Project with significant portal expansion, a 3,000-metre drilling program planned for Q2 2026, and trial mining of historic backfill and remnant pillars within a granted mining lease.

Anax Metals has released an updated Definitive Feasibility Study for its Whim Creek Copper Project, confirming robust economics with a pre-tax NPV of A$501 million and an IRR of 98%, underpinned by a 10-year mine life and rapid payback.

XPON Technologies has posted a strong H1 FY26 turnaround with a 58% revenue increase and a return to net profitability, driven by strategic acquisitions and operational improvements.

Radiopharm Theranostics has initiated dosing in its Phase 1/2a clinical trial of BetaBart, a novel radiotherapeutic developed with MD Anderson Cancer Center, targeting aggressive solid tumors.

Viva Energy Group Limited reported a significant net loss for 2025, driven by retail asset impairments, yet underlying profits and strategic investments signal resilience and a clear path forward.